Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
AN2 Therapeutics, Inc. (ANTX) had Return on Investments of -62.70% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-51.32M |
|
-- |
|
-- |
|
$56.79M |
|
$-56.79M |
|
$5.47M |
|
$-51.32M |
|
$-51.32M |
|
$-51.32M |
|
$-51.32M |
|
$-51.32M |
|
$-51.32M |
|
$-56.79M |
|
$-60.07M |
|
29.83M |
|
29.83M |
|
$-1.72 |
|
$-1.72 |
|
| Balance Sheet Financials | |
$86.26M |
|
-- |
|
$5.83M |
|
$92.09M |
|
$10.24M |
|
-- |
|
-- |
|
$10.24M |
|
$81.85M |
|
$81.85M |
|
$81.85M |
|
29.92M |
|
| Cash Flow Statement Financials | |
$-49.26M |
|
$54.59M |
|
$0.37M |
|
$15.65M |
|
$21.35M |
|
$5.70M |
|
$8.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-62.70% |
|
-62.70% |
|
-55.73% |
|
|
Return on Investments |
-62.70% |
$2.74 |
|
$-1.65 |
|
$-1.65 |
|